Although recent studies have provided statistical evidence implicating APOL1 variation in nondiabetic nephropathies[7, 33, 34], MYH9 risk variants are still associated with chronic kidney disease (CKD) in non-African American populations[35] and in sickle cell disease nephropathy[5]. Here, MYH9 is linked to kidney disorder.